Individual provider · Type 1 NPI
Justine Zuk
Oncology Pharmacist · Wilkes Barre, PA
NPI number
1205304342
Active
Practice location
1000 E Mountain Blvd
Wilkes Barre, PA 18711-0027
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Oncology Pharmacist Primary | 1835X0200X | RP452748 (PA) |
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
561 other providers at this address
- DR Robert Yanoshak Palliative Specialist LLCHospice and Palliative Medicine (Family Medicine) Physician Wilkes Barre, PA NPI 1457847162
- GeisingerGeneral Acute Care Hospital Wilkes Barre, PA NPI 1841114220
- Geisinger ClinicInternal Medicine Physician Wilkes Barre, PA NPI 1114295565
- Geisinger Health SystemGeneral Acute Care Hospital Wilkes Barre, PA NPI 1952392573
- Geisinger Wyoming Valley Medical CenterGeneral Acute Care Hospital Wilkes Barre, PA NPI 1275620585
- Geisinger Wyoming Valley Medical CenterRehabilitation Hospital Unit Wilkes Barre, PA NPI 1669553624
- Geisinger Wyoming Valley Medical CenterInstitutional Pharmacy Wilkes Barre, PA NPI 1942769393
- Aarushi Kalra, DOStudent in an Organized Health Care Education/Training Program Wilkes Barre, PA NPI 1154024214
- Abdullah SubhanStudent in an Organized Health Care Education/Training Program Wilkes-Barre, PA NPI 1396639001
- Abigail L. Chua, DONeurology Physician Wilkes Barre, PA NPI 1821381385
- Abisha PhudongStudent in an Organized Health Care Education/Training Program Wilkes Barre, PA NPI 1194528224
- Adil A. Khan, MDNeurology Physician Wilkes Barre, PA NPI 1538140884
Other oncology pharmacist providers in Wilkes Barre
About NPI 1205304342
Justine Zuk's National Provider Identifier is 1205304342, issued on Nov 7, 2018. The primary taxonomy on file is Oncology Pharmacist (1835X0200X), and the practice location is in Wilkes Barre, PA. The record was last updated on Nov 20, 2024.